Otsuka Pharm Co Ltd
1 products tracked · names used in filings: Otsuka Pharm Co Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 25 Nov 2025🇺🇸 FDA approval
FDA approves Voyxact (sibeprenlimab-szsi), a new medicine
Otsuka Pharm Co Ltd; BLA761434; New biologic, Priority review; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Voyxact sibeprenlimab-szsi | Approved | 2025-11-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.